NCT05245942

Brief Summary

The objective of this registry is to confirm the safety and the performance of the ECE50 in medical routine by collecting data.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
384

participants targeted

Target at P75+ for all trials

Timeline
69mo left

Started Dec 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Dec 2021Dec 2031

Study Start

First participant enrolled

December 16, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

December 22, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 18, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2031

Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

5.1 years

First QC Date

December 22, 2021

Last Update Submit

January 15, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Confirm the safety

    Adverse event report analysis

    Immediately after the intervention

  • Assess the performance of the ECE50

    Comparison between the result of the ECE50 stimulation, Laryngeal Electromyography (LEMG), videolaryngoscopy

    During the intervention

Secondary Outcomes (1)

  • Standardize the medical procedure for the ECE50

    Immediately after the intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Target population: adults of both sexes who, in the expert opinion of the registry responsible is in need of an ECE50 examination * Accessible population: target population matching the selection criteria * Intended population: accessible population that can be recruited by the registry sites * Actual population: intended population who signed the ICF * Analytic population: actual population compatible with PP analysis

You may qualify if:

  • Legal adults (i.e., as a general rule patients ≥ 18 years old)
  • Legal adults requiring a diagnosis for a disorder that could be traced back to uni- or bilateral dysfunction of one or more laryngeal muscle(s) of the posterior cricoid region
  • Signed and dated informed consent before the start of any registry-specific procedure for all the recruited subjects

You may not qualify if:

  • Use of an active medical implant
  • Known allergies or intolerance to the material used for this registry
  • Parallel participation in a device/drug registry in the period of data collection, which could confound the results of the registry
  • Anything that, in the opinion of the Registry Responsible, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univ. Klinik für Hals-, Nasen- und Ohrenkrankheiten

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Dysphonia

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Berit Schneider-Stickler, Prof.Dr.med.

    Univ. Klinik für Hals-, Nasen- und Ohrenkrankheiten, Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2021

First Posted

February 18, 2022

Study Start

December 16, 2021

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

December 16, 2031

Last Updated

January 16, 2026

Record last verified: 2026-01

Locations